Zimmer Biomet Holdings, Inc.
ZBH
Rangering i aksjer
#1244
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing... Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Aksjekurs
$95.94
Sist synkronisert: 2026-10-20
Markedsverdi
$18.30B
Endring (1 dag)
0.92%
Endring (1 år)
-6.57%
Land
US
Handel Zimmer Biomet Holdings, Inc. (ZBH)
Kategori
Healthcare
Antall utestående aksjer for Zimmer Biomet Holdings, Inc. (ZBH)
Antall utestående aksjer per June 2026: 192.20M
Ifølge Zimmer Biomet Holdings, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 192.20M. Ved slutten av December 2024 hadde selskapet 203.10M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Zimmer Biomet Holdings, Inc. (ZBH) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 192.20M | -2.93% |
| 2025 | 198.00M | -2.51% |
| 2024 | 203.10M | -2.68% |
| 2023 | 208.70M | -0.43% |
| 2022 | 209.60M | 0.48% |
| 2021 | 208.60M | 0.77% |
| 2020 | 207.00M | 0.93% |
| 2019 | 205.10M | 0.79% |
| 2018 | 203.50M | 0.79% |
| 2017 | 201.90M | 0.95% |
| 2016 | 200.00M | 6.72% |
| 2015 | 187.40M | 10.89% |
| 2014 | 169.00M | -0.35% |
| 2013 | 169.60M | -3.03% |
| 2012 | 174.90M | -6.77% |
| 2011 | 187.60M | -6.20% |
| 2010 | 200.00M | -6.98% |
| 2009 | 215.00M | -5.41% |
| 2008 | 227.30M | -3.48% |
| 2007 | 235.50M | -3.09% |
| 2006 | 243.00M | -1.66% |
| 2005 | 247.10M | 1.10% |
| 2004 | 244.40M | 17.67% |
| 2003 | 207.70M | 6.79% |
| 2002 | 194.50M | 0.41% |
| 2001 | 193.70M | 0.05% |
| 2000 | 193.60M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 1.74B | 806.89% |
US
|
|
| 1.28B | 567.07% |
IE
|
|
| 383.50M | 99.53% |
US
|
|
| 1.48B | 668.78% |
US
|
|
| - | - |
DE
|
